(PharmaNewsWire.Com, May 27, 2020 ) The surgical navigations systems market is highly competitive with the presence of various established as well as emerging players. Some of key players in this market include Medtronic plc (Ireland), Stryker Corporation (U.S.), Brainlab AG (Germany), B. Braun Melsungen AG (Germany), Scopis GmbH (Germany), Fiagon AG (Germany), Karl Storz GmbH & Co. KG (Germany), Amplitude Surgical (France), Zimmer Biomet Holdings, Inc. (U.S.), and Siemens Healthineers (Germany).
Other players in the market include companies such as Synaptive Medical, Inc. (U.S.), Sonowand AS (Norway), Olympus Corporation (Japan), Xion GmbH (Germany), ClaroNav (Canada), X-Nav Technologies, LLC (U.S.), Inliant Dental Technologies (Canada), Image Navigation (Israel), Anke (China), Blue Belt Technologies (U.S.), Collin Medical (France), Surgical Theatre LLC (U.S.), OrthoAlign, Inc. (U.S.), and 7D Surgical, Inc. (U.S).
Companies are focusing on organic as well as inorganic growth strategies such as product launches and product approvals; agreements, partnerships, and collaborations; expansion; and acquisitions. Product launches and product approvals accounted for the largest share of the overall growth strategies adopted by market players between 2013 and 2016. Various new and technologically advanced products were launched during this period. For instance, in March 2015, Stryker launched the PROFESS system, a surgical navigation system for image-guided endoscopic sinus surgery. This system is integrated with surgical navigation software that utilizes video tracking capabilities. Also, in October 2014, Brainlab introduced Knee 3, orthopedic navigation software used in image-guided surgery for total knee replacement. This enabled the company to expand its product offerings in the market. In addition to the product launches, prominent players in this market received product approvals to market their products in the global surgical navigation systems market. Some of the recent product approvals include brain navigation system (Fiagon AG) (April 2016); ENT navigation instruments (Fiagon AG) (March 2016); Expanded indication of StealthStation electromagnetic (EM) surgical navigation system instruments for pediatric and adult cranial ENT procedures (Medtronic plc) (May 2015).
Such product launches and approvals help companies to enhance their product offerings and leverage the growth opportunities in this market. Key players who adopted this growth strategy include Medtronic plc (Ireland), Stryker Corporation (U.S.), Brainlab AG (Germany), Scopis GmbH (Germany), and Fiagon GmbH (Germany). This strategy enabled market players to expand their product portfolio in the surgical navigation systems market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
